ATE433439T1 - Anthranyl-derivate mit anti-cholecystokinin- aktivität (anti-cck-1) verfahren zu deren herstellung und deren pharmazeutische anwendung - Google Patents
Anthranyl-derivate mit anti-cholecystokinin- aktivität (anti-cck-1) verfahren zu deren herstellung und deren pharmazeutische anwendungInfo
- Publication number
- ATE433439T1 ATE433439T1 AT03766505T AT03766505T ATE433439T1 AT E433439 T1 ATE433439 T1 AT E433439T1 AT 03766505 T AT03766505 T AT 03766505T AT 03766505 T AT03766505 T AT 03766505T AT E433439 T1 ATE433439 T1 AT E433439T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- chosen
- group
- cck
- production
- Prior art date
Links
- -1 ANTHRANYL Chemical class 0.000 title 1
- 229940107137 cholecystokinin Drugs 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000392 cycloalkenyl group Chemical group 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2002TO000674A ITTO20020674A1 (it) | 2002-07-26 | 2002-07-26 | Derivati antranilici ad attivita' anticolecistochininica (anti-cck-1), procedimento per la loro preparazione e loro uso farmaceutico |
| PCT/IB2003/002922 WO2004013087A1 (en) | 2002-07-26 | 2003-07-23 | Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE433439T1 true ATE433439T1 (de) | 2009-06-15 |
Family
ID=11459544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03766505T ATE433439T1 (de) | 2002-07-26 | 2003-07-23 | Anthranyl-derivate mit anti-cholecystokinin- aktivität (anti-cck-1) verfahren zu deren herstellung und deren pharmazeutische anwendung |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7294648B2 (de) |
| EP (1) | EP1532105B1 (de) |
| JP (1) | JP4530853B2 (de) |
| AT (1) | ATE433439T1 (de) |
| AU (1) | AU2003253114B8 (de) |
| CA (1) | CA2493789C (de) |
| DE (1) | DE60327932D1 (de) |
| ES (1) | ES2325496T3 (de) |
| IT (1) | ITTO20020674A1 (de) |
| PT (1) | PT1532105E (de) |
| WO (1) | WO2004013087A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20050119666A (ko) | 2003-03-28 | 2005-12-21 | 얀센 파마슈티카 엔.브이. | 벤조[1,2,5]티아디아졸 화합물 |
| MXPA06001482A (es) * | 2003-08-08 | 2006-09-04 | Johnson & Johnson | Procedimiento para la preparacion de compuestos de 2-(quinoxalin-5-ilsulfonilamino)-benzamida. |
| KR20070057252A (ko) | 2004-09-24 | 2007-06-04 | 얀센 파마슈티카 엔.브이. | 설폰아미드 화합물 |
-
2002
- 2002-07-26 IT IT2002TO000674A patent/ITTO20020674A1/it unknown
-
2003
- 2003-07-23 CA CA2493789A patent/CA2493789C/en not_active Expired - Fee Related
- 2003-07-23 JP JP2004525597A patent/JP4530853B2/ja not_active Expired - Fee Related
- 2003-07-23 US US10/523,075 patent/US7294648B2/en not_active Expired - Fee Related
- 2003-07-23 PT PT03766505T patent/PT1532105E/pt unknown
- 2003-07-23 AT AT03766505T patent/ATE433439T1/de not_active IP Right Cessation
- 2003-07-23 WO PCT/IB2003/002922 patent/WO2004013087A1/en not_active Ceased
- 2003-07-23 EP EP03766505A patent/EP1532105B1/de not_active Expired - Lifetime
- 2003-07-23 AU AU2003253114A patent/AU2003253114B8/en not_active Ceased
- 2003-07-23 DE DE60327932T patent/DE60327932D1/de not_active Expired - Lifetime
- 2003-07-23 ES ES03766505T patent/ES2325496T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003253114B2 (en) | 2009-07-16 |
| AU2003253114A1 (en) | 2004-02-23 |
| PT1532105E (pt) | 2009-06-29 |
| ITTO20020674A1 (it) | 2004-01-26 |
| EP1532105B1 (de) | 2009-06-10 |
| JP4530853B2 (ja) | 2010-08-25 |
| JP2005533866A (ja) | 2005-11-10 |
| CA2493789A1 (en) | 2004-02-12 |
| US20060111304A1 (en) | 2006-05-25 |
| US7294648B2 (en) | 2007-11-13 |
| WO2004013087A1 (en) | 2004-02-12 |
| ITTO20020674A0 (it) | 2002-07-26 |
| EP1532105A1 (de) | 2005-05-25 |
| AU2003253114B8 (en) | 2009-08-13 |
| DE60327932D1 (de) | 2009-07-23 |
| CA2493789C (en) | 2012-05-01 |
| ES2325496T3 (es) | 2009-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1548008A4 (de) | Verbindung mit tgf-beta-hemmender wirkung und diese enthaltende medizinische zusammensetzung | |
| BRPI0413232B8 (pt) | composto tendo atividade inibitória contra transportador dependente de sódio, composição farmacêutica compreendendo o composto, uso do composto na preparação de um medicamento e processo para a preparação do composto | |
| NO940737D0 (no) | Antidepressive midler | |
| FR2654104B1 (fr) | Nouveaux derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. | |
| AR039868A1 (es) | Inhibidores selectivos de la enzima kalikreina plasmatica | |
| EA200201056A1 (ru) | Новые, обладающие продолжительным действием бетамиметики, способ их получения и их применение в качестве лекарственных средств | |
| DE602004012758D1 (de) | Chinoxalinderivate als inhibitoren der neutrophilelastase und deren verwendung | |
| FI970317A0 (fi) | Antiproliferatiivisina aineina ja Garft-inhibiittoreina käyttökelpoisia yhdisteitä | |
| ES2093332T3 (es) | Nuevos derivados arilglicinamidicos, su procedimiento de preparacion y su uso para el tratamiento de la disuria. | |
| ATE266664T1 (de) | Pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
| DK1320526T3 (da) | Farmaceutisk aktive benzsulfonamidderivater som inhibitorer af protein-junkinaser | |
| DK1644389T3 (da) | Pyrinidinforbindelser med phosphonatgrupper som antivirale nukleotidanaloger | |
| PT790248E (pt) | Derivados de 3-aza-piperidona-(tetra-hidropirimidin-2-ona) e 3-oxa-piperidona(1,3 oxazin-2-ona) sua preparacao e uso como antagonistas de taquicinina/neurocinina | |
| DE69132689D1 (de) | Biologisch aktive amine | |
| ATE433439T1 (de) | Anthranyl-derivate mit anti-cholecystokinin- aktivität (anti-cck-1) verfahren zu deren herstellung und deren pharmazeutische anwendung | |
| EP0712398A1 (de) | Benzopyrane und diese enthaltende pharmazeutische zusammenstellungen | |
| ATE265451T1 (de) | 2-aminoidan derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen | |
| DE69204859D1 (de) | Substituierte Pyridinsulfonamide oder deren Salze, Verfahren zur Herstellung und diese enthaltende Herbizide. | |
| AR045600A1 (es) | Tienoimidazoles sustituidos, procedimiento para su preparacion, su uso como un medicamento o adyuvante de diagnostico y medicamento que los comprende | |
| EP1178031A4 (de) | Verfahren zur herstellung organischer verbindungen mit mangankatalysatoren oder ähnlichen verbindungen | |
| ATE195936T1 (de) | Bis-imide derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitung | |
| DE69409774D1 (de) | Neue kardioaktive 17-Iminomethylalkenyl-5-beta-14-beta-androstan und 17-Iminoalkyl-5-beta, 14-beta-androstan Derivate, ein Verfahren zu ihrer Herstellung und pharmazeutische Präparate davon | |
| ATE191458T1 (de) | Benzol-derivate | |
| DE69011748D1 (de) | Biphenyl-Derivate, Verfahren zu deren Herstellung und deren Zwischenprodukte. | |
| MY111111A (en) | Novel (1-phenyl-1-heterocyclyl) methanol and (1-phenyl -1-heterocyclyl) methylamine drrivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |